qSOFA as a new community-acquired pneumonia severity score in the emergency setting

被引:4
|
作者
Spagnolello, Ornella [1 ,2 ]
Ceccarelli, Giancarlo [2 ]
Borrazzo, Cristian [3 ]
Macri, Angela [1 ]
Suppa, Marianna [1 ]
Baldini, Enrico [1 ]
Garramone, Alessia [1 ]
Alessandri, Francesco [4 ]
Celani, Luigi [2 ]
Vullo, Francesco [5 ]
Angeletti, Silvia [6 ]
Ciccozzi, Massimo [7 ]
Mastroianni, Claudio [2 ]
Bertazzoni, Giuliano [1 ]
D'Ettorre, Gabriella [2 ]
机构
[1] Univ Roma La Sapienza, Dept Emergency Med, Rome, Lazio, Italy
[2] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Lazio, Italy
[3] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Stat Unit, Rome, Lazio, Italy
[4] Univ Roma La Sapienza, Dept Anesthesia & Intens Care Med, Rome, Lazio, Italy
[5] Univ Roma La Sapienza, Dept Radiol Ontol & Anatomo Pathol Sci, Rome, Lazio, Italy
[6] Univ Rome, Fac Med & Surg, Univ Campus Biomed, Unit Clin Lab Sci, Rome, Lazio, Italy
[7] Univ Rome, Fac Med & Surg, Univ Campus Biomed, Unit Med Stat & Mol Epidemiol, Rome, Lazio, Italy
关键词
pneumonia; infections; death; mortality; emergency department; clinical assessment; intensive care; INFECTIOUS-DISEASES-SOCIETY; VALIDATION; GUIDELINES; MANAGEMENT; MORTALITY; SEPSIS;
D O I
10.1136/emermed-2019-208789
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Quick Sequential Organ Failure Assessment (qSOFA) score is a bedside prognostic tool for patients with suspected infection outside the intensive care unit (ICU), which is particularly useful when laboratory analyses are not readily available. However, its performance in potentially septic patients with community-acquired pneumonia (CAP) needs to be examined further, especially in relation to early outcomes affecting acute management. Objective First, to compare the performance of qSOFA and CURB-65 in the prediction of mortality in the emergency department in patients presenting with CAP. Second, to study patients who required critical care support (CCS) and ICU admission. Methods Between January and December 2017, a 1-year retrospective observational study was carried out of adult (>= 18 years old) patients presenting to the emergency department (ED) of our hospital (Rome, Italy) with CAP. The accuracy of qSOFA, qSOFA-65 and CURB-65 was compared in predicting mortality in the ED, CCS requirement and ICU admission. The concordance among scores >= 2 was then assessed for 30-day estimated mortality prediction. Results 505 patients with CAP were enrolled. Median age was 71.0 years and mortality rate in the ED was 4.7%. The areas under the curve (AUCs) of qSOFA-65, CURB-65 and qSOFA in predicting mortality rate in the ED were 0.949 (95% CI 0.873 to 0.976), 0.923 (0.867 to 0.980) and 0.909 (0.847 to 0.971), respectively. The likelihood ratio of a patient having a qSOFA score >= 2 points was higher than for qSOFA-65 or CURB-65 (11 vs 7 vs 6.7). The AUCs of qSOFA, qSOFA-65 and CURB-65 in predicting CCS requirement were 0.862 (95% CI 0.802 to 0.923), 0.824 (0.758 to 0.890) and 0.821 (0.754 to 0.888), respectively. The AUCs of qSOFA-65, qSOFA and CURB-65 in predicting ICU admission were 0.593 (95% CI 0.511 to 0.676), 0.585 (0.503 to 0.667) and 0.570 (0.488 to 0.653), respectively. The concordance between qSOFA-65 and CURB-65 in 30-day estimated mortality prediction was 93%. Conclusion qSOFA is a valuable score for predicting mortality in the ED and for the prompt identification of patients with CAP requiring CCS. qSOFA-65 may further improve the performance of this useful score, showing also good concordance with CURB-65 in 30-day estimated mortality prediction.
引用
收藏
页码:906 / 912
页数:7
相关论文
共 50 条
  • [1] The role of qSOFA score and biomarkers in assessing severity of community-acquired pneumonia in adults
    Tripon, Raluca-Elena
    Cristea, Victor
    Lupse, Mihaela-Sorina
    [J]. REVISTA ROMANA DE MEDICINA DE LABORATOR, 2021, 29 (01): : 65 - 75
  • [2] A new severity score for community-acquired pneumonia: PARB score
    N Uchiyama
    R Suda
    S Yamao
    Y Tomishima
    T Jinta
    N Nishimura
    N Chohnabayashi
    [J]. Critical Care, 14 (Suppl 1):
  • [3] A Powerful New Severity Score for Community-Acquired Pneumonia But Will Anyone Use It?
    Chalmers, James D.
    Hill, Adam T.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 (10) : 1363 - 1363
  • [4] The prognostic performance of qSOFA for community-acquired pneumonia
    Tokioka, Fumiaki
    Okamoto, Hiroshi
    Yamazaki, Akio
    Itou, Akihiro
    Ishida, Tadashi
    [J]. JOURNAL OF INTENSIVE CARE, 2018, 6
  • [5] The prognostic performance of qSOFA for community-acquired pneumonia
    Fumiaki Tokioka
    Hiroshi Okamoto
    Akio Yamazaki
    Akihiro Itou
    Tadashi Ishida
    [J]. Journal of Intensive Care, 6
  • [6] PIRO score for community-acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia
    Rubulotta, F.
    Ramsay, D.
    Williams, Mark D.
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (04) : 1236 - 1236
  • [7] PIRO score for community-acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia
    Rello, Jordi
    Rodriguez, Alejandro
    Lisboa, Thiago
    Gallego, Miguel
    Lujan, Manel
    Wunderink, Richard
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (02) : 456 - 462
  • [8] Expanded A-DROP Score: A New Score System Predicts the Severity of Community-Acquired Pneumonia
    Ahn, J.
    Lee, K.
    Chung, J.
    Shin, K.
    Jin, H.
    Kim, J.
    Choi, E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] USEFULNESS OF QSOFA WITH LACTATE TO PREDICT MORTALITY IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN THE EMERGENCY DEPARTMENT
    Kim, Hyo Joon
    Kim, Soo Hyun
    [J]. RESPIROLOGY, 2017, 22 : 232 - 232
  • [10] Validation of the qSOFA score compared to the CRB-65 score for risk prediction in community-acquired pneumonia
    Kesselmeier, Miriam
    Pletz, Mathias W.
    Blankenstein, Anna Leona
    Scherag, Andre
    Bauer, Torsten
    Ewig, Santiago
    Kolditz, Martin
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1345.e1 - 1345.e6